26
financial markets
COMPANY
QUOTE
European Biotechnology | Summer Edition | Vol. 17 | 2018
M-Cap
52 weeks indicator low high
COMPANY
QUOTE
M-Cap
4D Pharma plc
1.58
100,000k
C4X Discovery Holdings plc
1.04
48,000k
4SC AG
5.00
160,000k
Cantargia AB
1.54
99,000k
A1M Pharma AS
0.38
3,000k
Carbios SAS
7.25
34,000k
AB Science SA
4.28
175,000k
Cassiopea SpA
31.16
310,000k
Cellectis SA
24.86
1,100,000k
Cellink AB
13.24
100,000k
7.39
330,000k
24.60
280,000k
AB-Biotics SA
3.20
40,000k
Abcam plc
14.20
2,900,000k
Abivax SA
6.65
66,000k
Celon Pharma SA
Abzena plc
0.21
45,000k
Celyad SA
Acarix AB
0.85
20,000k
Cerenis Therapeutics SA
1.94
37,000k
Active Biotech AB
0.24
38,000k
Circassia Pharmaceuticals plc
1.05
340,000k
Not afraid of vertigo Otology It’s been an exciting first half of the year for listed
French drug developer Sensorion. After identifying a new potential blood biomarker for noise-induced hearing loss, the outer hair cell protein prestin, the company successfully raised €8.65m from institutional investors through a capital increase in May. But the newsflow is not going to stop anytime soon. Still this year, data from a Phase II study in a severe form of vertigo, namely acute unilateral vestibulopathy, with Sensorion’s lead candidate SENS-111 (Seliforant) is expected. The molecule belongs to a new class of histamine type 4 receptor antagonists. L
Co.don AG
6.52
120,000k
100.42
1,500,000k
Curetis AG
5.54
85,000k
Cytotools AG
8.48
19,000k
Cyxone AB
0.66
12,000k
DBV Technologies SA
36.14
1,100,000k
Cosmo Pharmaceuticals NV
Deinove SA
3.34
42,000k
Destiny Pharma plc
1.25
54,000k
Diamyd Medical AB
0.41
23,000k
88.95
5,000,000k
Diaxonhit Therapeutics SA
4.85
48,000k
Elanix Technologies AG
1.72
14,000k
e-Therapeutics plc
0.08
22,000k
Diasorin SpA
Ellen AB
0.03
5,400k
Enzymatica AB
0.38
28,000k
Epigenomics AG Erytech Pharma SA
2.51
75,000k
15.86
290,000k
Addex Therapeutics Ltd
2.55
73,000k
Esperite NV
ADL Bionatur Solutions SA
2.24
76,000k
Eurofins Scientific SE
Adocia SAS
18.80
130,000k
Evgen Pharma plc
0.31
23,000k
Advicenne SACA
12.07
97,000k
Evolva SA
0.22
170,000k
ALK-Abelló A/S
Evotec AG
14.89
2,200,000k
0.38
10,000k
424.20
7,500,000k
143.71
1,600,000k
Allergy Therapeutics plc
0.31
180,000k
Expres2ion Biotech Holding AB
0.77
9,500k
Alligator Bioscience AB
3.05
220,000k
Faron Pharmaceuticals Oy
1.33
39,000k
Annexin Pharmaceuticals AB
0.36
2,100k
Fermentalg SA
3.57
60,000k
Aqua Bio Technology ASA
0.62
4,200k
Fit Biotech Oy
0.00
1,500k
Argenx SE
85.80
2,800,000k
Formycon AG
36.90
340,000k
Arocell AB
0.68
27,000k
Galapagos NV
87.28
4,400,000k
Asit Biotech SA
3.79
62,000k
Genedrive plc
0.43
7,900k
Avacta Group plc
0.39
27,000k
Geneuro SA
5.94
87,000k
Avantium Holding NV
5.84
150,000k
Genfit SA
23.88
750,000k
Basilea Pharmaceutica AG
60.42
720,000k
Genmab A/S
128.61
7,900,000k
Bavarian Nordic A/S
26.72
860,000k
Genomed SA
5.52
7,600k
4.47
240,000k
Genomic Vision SA
1.22
7,200k
Bio-On SpA
42.00
800,000k
Genovis AB
0.38
23,000k
Biocartis NV
12.70
650,000k
Genoway SA
1.69
10,000k
5.58
260,000k
Gensight Biologics SA
3.33
81,000k
39.49
690,000k
Genkyotex SA
1.67
130,000k
Bioinvent International AB
0.19
69,000k
Genus plc
30.14
1,800,000k
Biomed-Lublin SA
0.28
18,000k
Global Bioenergies SA
16.00
72,000k
77.20
9,300,000k
Hansa Medical AB
22.11
840,000k
Bergenbio ASA
Biofrontera AG Biogaia AB
Biomérieux SA Biophytis
2.76
37,000k
Heidelberg Pharma AG
2.61
74,000k
Bioporto Diagnostics A/S
0.42
64,000k
Herantis Pharma Oyj
6.50
32,000k
Biosearch Life SA
1.25
74,000k
Hofseth Biocare ASA
0.20
47,000k
Biotec Pharmacon ASA
0.59
25,000k
Horizon Discovery Group plc
1.84
290,000k
31.58
170,000k
Hvivo plc
0.24
19,000k
0.91
17,000k
Hybrigenics SA
0.52
23,000k
Idorsia Ltd.
22.33
2,600,000k
0.68
34,000k
Bioventix plc Biovica International AB Bone Therapeutics SA
11.46
87,000k
Brain AG
21.10
390,000k
26-27_EB_Summer_2018_stock-list2_ml.indd 26
Immunicum AB
52 weeks indicator low high
13.06.2018 15:32:33 Uhr